Arena will host a conference call and webcast today, June 27, 2012, at 2 p.m. Eastern Time (11 a.m. Pacific Time) to provide a business update. The conference call may be accessed by dialing 877.643.7155 for domestic callers and 914.495.8552 for international callers.
SAO PAULO , Dec. 7, 2011 /PRNewswire/ -- GOL Linhas Aereas Inteligentes S.A. (BM&FBovespa: GOLL4 and NYSE: GOL), (S&P/Fitch: BB-/BB-, Moody's: B1) (the "Company"), the largest low-cost and low-fare airline in Latin America , in compliance with CVM Instruction 358/2002 ("CVM Instruction 358"), hereby informs its shareholders and the market in general that it signed a binding agreement involving the acquisition by the U.S. company, Delta Air Lines, Inc. (NYSE: DAL - News) of a strategic minority interest of US$100 million of GOL´s preferred shares.
There will be a conference call with a presentation on this material fact, whose details are shown below:
The bashers are back, which can only mean that they are nervous. This is positive news. This is a shareholder friendly way to save cash. Rock solid company with an approval and 27 million + pending sales. It's going to be a great holiday season! Bashers on ignore.
Prior to joining ICR, Donald Ellis was a Partner and a Senior Equities Research Analyst covering Specialty Pharmaceuticals at Thomas Weisel Partners for 9 years. Previously, he was a Managing Director and Senior Pharmaceutical Analyst at Robertson Stephens and Montgomery Securities and in total has 15 years of senior-level Wall Street experience. In 1998, 2001 and in 2006, The Wall Street Journal named him a �Best on the Street Analyst� for his coverage of the Drug Delivery and Specialty Pharmaceuticals sector. Before entering the securities business, he spent ten years in clinical practice at Kaiser Permanente and at the Veterans Administration Hospital in San Diego, California. Donald received a Master of Business Administration degree from the University of San Diego and a Doctorate degree in Pharmacy from the University of Southern California.
Yes, finally, qualified a PR person. I see that Dr. Ellis, was a resident at the VA hospital in San Diego, which could provide for some interesting investment possibilities with the US government. Onsolsis being used for breakthrough pain in VA hospitals? A nice fat US gov't contract? Let's get this show on the road.